Skip to main content
. Author manuscript; available in PMC: 2013 Nov 13.
Published in final edited form as: Cancer Chemother Pharmacol. 2009 Dec 4;66(3):10.1007/s00280-009-1181-8. doi: 10.1007/s00280-009-1181-8

Fig. 1.

Fig. 1

Antiproliferative effect of Velcade on MPM a and HBC b cells. Cells were treated with vehicle (Control) or indicated doses of Velcade for 48 h. Determination of viable/live cells was carried out by MTT assay. Columns in each of the histograms represent means of 3–4 independent experiments; bars SE